Results 221 to 230 of about 435,005 (359)

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT‐HF): Baseline characteristics compared to recent randomized controlled heart failure trials

European Journal of Heart Failure, EarlyView.
Effects of digitoxin compared to placebo on efficacy and safety in patients with heart failure and reduced ejection fraction (HFrEF). Primary endpoint: time to all‐cause death and first hospitalization for worsening heart failure (whatever occurs first). ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin
Udo Bavendiek, Nele Henrike Thomas, Dominik Berliner, Xiaofei Liu, Johannes Schwab, Andreas Rieth, Lars S. Maier, Sven Schallhorn, Eleonora Angelini, Samira Soltani, Fabian Rathje, Mircea‐Andrei Sandu, Welf Geller, Thomas Gaspar, Rainer Hambrecht, Marija Zdravkovic, Sebastian Philipp, Dragana Kosevic, Georg Nickenig, Daniel Scheiber, Sebastian Winkler, Peter Moritz Becher, Philipp Lurz, Martin Hülsmann, Maria von Karpowitz, Christoph Schröder, Barbara Neuhaus, Anika Seltmann, Heiko von der Leyen, Christian Veltmann, Stefan Störk, Michael Böhm, Armin Koch, Anika Großhennig, Johann Bauersachs, on behalf of the DIGIT‐HF Study Group   +35 more
wiley   +1 more source

Hemiarthroplasties via Posterior Trochanter Osteotomy for Treating Femoral Neck Fractures in Post-Cerebrovascular Disease. [PDF]

J Multidiscip Healthc
Jia YA, Qiao LN, Liu ZB, Xue L, Bi WM, Chen MF, Kang K, Wang F.   +7 more
europepmc   +1 more source

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study

European Journal of Heart Failure, EarlyView.
ABSTRACT Aims In clinical practice, simplifying the number of medication titration steps while maintaining safety may improve the likelihood of patients with heart failure (HF) achieving target doses of guideline‐directed medical therapy (GDMT).
Stephen J. Greene, Stefano Corda, Ciaran J. McMullan, Giovanni Palombo, Christina Schooss, Vanja Vlajnic, Katrin Walkamp, Michele Senni, on behalf of the VELOCITY investigators   +8 more
wiley   +1 more source

Cerebrovascular Disease and Late-Life Depression: A Scoping Review. [PDF]

Cureus
Kalim HA, Hussain T, Colon M, Fonseca G, Shenoy A, Mayrovitz HN.   +5 more
europepmc   +1 more source

Employ machine learning to identify NAD+ metabolism-related diagnostic markers for ischemic stroke and develop a diagnostic model

Experimental Gerontology
Ischemic stroke (IS) is a severe condition regulated by complex molecular alterations. This study aimed to identify potential nicotinamide adenine dinucleotide (NAD+) metabolism-associated diagnostic markers of IS and explore their associations with ...
Yameng Sun, Shenghao Ding, Fei Shen, Xiaolan Yang, Wenhua Sun, Jieqing Wan   +5 more
doaj  

Clinical Significance of Serum Creatine Phosphokinase Activity in Cerebrovascular Diseases

, 1971
Toshimitsu Kotoku, Hiroshi Kawakami, TAKAYUKI IWABUCHI, Tsutomu Sato, Takashi Kutsuzawa, Takashi Nakamura   +5 more
openalex   +2 more sources

Primer on cerebrovascular diseases [PDF]

Journal of Vascular Surgery, 1998
Robert A. Egan, Wayne M. Clark
openaire   +2 more sources

Onset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts. [PDF]

Brain Commun
Du L, Planalp EM, Betthauser TJ, Jonaitis EM, Hermann BP, Rivera-Rivera LA, Cody KA, Chin NA, Cadman RV, Johnson KM, Field A, Rowley HA, Mueller KD, Asthana S, Eisenmenger L, Christian BT, Johnson SC, Langhough RE.   +17 more
europepmc   +1 more source

The smoking epidemic in England [PDF]

, 2004
Moon, G., Twigg, Liz, Walker, S.
core  

Insights into the interconnection of sarcopenia in heart failure

ESC Heart Failure, Volume 12, Issue 4, Page 2605-2607, August 2025.
Zhengyang Ge, Yanming Wu, Biao Wang
wiley   +1 more source